Introduction and Technical Aspects
Needle aspiration cytology has been in use for many decades and dates back at least to the early part of the nineteenth century. Sir James Paget is credited for aspirating malignant cells from a breast cancer patient in 1853. Much of the early experience of aspiration biopsy was not with “fine” needles but with larger bore cutting needles. The popularity of this simple procedure has largely been because of its cost effectiveness as well as the inherent qualities of the procedure itself: low complication rate, rapidity, and high diagnostic accuracy.
KeywordsTechnical Aspect Breast Lesion Myoepithelial Cell Gray Zone Direct Smear
Unable to display preview. Download preview PDF.
- Sidawy MK, Stoler MH, Frable WJ, Frost AR, Masood S, Miller TR, Silverberg SG, Sneige N, Wang HH: Interobserver variability in the classification of proliferative breast lesions by fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Study. Diagn Cytopathol 1998, 18:150–165.PubMedCrossRefGoogle Scholar